Health Trials

Malignant Pleural Effusions

2

Review clinical trials related to Malignant Pleural Effusions. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC

This is a phase 1/phase 2, multicenter, open-label study to evaluate the safety, tolerability, PK, PD, immunogenicity and preliminary efficacy of M701 in patients with treatment of malignant pleural effusions caused by NSCLC.

Participants needed: 116
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Wuhan YZY Biopharma Co., Ltd.Updated: Jul 8, 2026Locations: 1
Eligibility criteria

Aged >18 years and ≤ 75 years, male or female. [+6]

Subjects with recurrent pleural effusion within 4 weeks after the last intrathor... [+16]

Read more
Status: Not yet recruiting

WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)

This is a prospective, single-center, interventional, phase I, dose-escalation, single-arm study designed to evaluate the safety, tolerability, and preliminary efficacy of intrapleural/intraperitoneal infusion of WSK-IM02 in patients with advanced solid tumors complicated by malignant pleural or peritoneal effusions who have failed standard of care.

Participants needed: 9
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: WestVac Biopharma Co., Ltd.Updated: May 29, 2026Locations: 1
Eligibility criteria

Age ≥18 years and ≤75 years. [+8]

Participation in any other interventional clinical trial within 4 weeks prior to... [+18]

Read more